Figure 5From: Reduction of delayed onset muscle soreness by a novel curcumin delivery system (Meriva®): a randomised, placebo-controlled trialSarcolemmal damage and acute inflammatory response to exercise. CD3+, CD positive cells; MPO, myeloperoxidase.Back to article page